About 1 result found for searched term "Tigatuzumab" (0.125 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M25291 | Tigatuzumab | Apoptosis |
| CS-1008; Anti-Human TRAIL-R2 Recombinant Antibody | ||
| Tigatuzumab (CS-1008) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). Tigatuzumab induces cell apoptosis of cancer cells and inhibits tumor growth in vivo. Tigatuzumab can be used for the research of cancer. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
